<?xml version="1.0" encoding="UTF-8"?>
<ref id="B165-ijerph-17-05648">
 <label>165.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Lan</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Qi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Bao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</article-title>
  <source>Cell Res.</source>
  <year>2020</year>
  <volume>30</volume>
  <fpage>343</fpage>
  <lpage>355</lpage>
  <pub-id pub-id-type="doi">10.1038/s41422-020-0305-x</pub-id>
  <?supplied-pmid 32231345?>
  <pub-id pub-id-type="pmid">32231345</pub-id>
 </element-citation>
</ref>
